COMMUNIQUÉS West-GlobeNewswire
-
Most Popular Legal Steroids for Muscle Building from CrazyBulk: Legal Steroid Alternatives for Lean Muscle Growth and Cutting in 2026
03/12/2025 -
Protara Therapeutics Announces Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients
03/12/2025 -
Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval
03/12/2025 -
Catheter Precision Secures Tender From Leading Hospital in Hungary
03/12/2025 -
NKGen Biotech, Inc. Issues Statement on Recent Board Appointments at Majority-Owned Korean Affiliate NKGen Korea Co., Ltd.
03/12/2025 -
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings
03/12/2025 -
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
03/12/2025 -
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting
03/12/2025 -
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
03/12/2025 -
Soligenix Inc. (NASDAQ: SNGX) Innovative Platform Provides Novel Treatment for Underserved CTCL Space
03/12/2025 -
Ob Hospitalist Group Launches Commure’s Autonomous Coding to Support Clinicians and Strengthen Coding Accuracy
03/12/2025 -
QHSLab (OTCQB:USAQ) Announces Launch of Q-Cog™ to Support Early Detection of Mild Cognitive Impairment and Dementia
03/12/2025 -
Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI®) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid Leukemia
03/12/2025 -
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™
03/12/2025 -
Key Narmafotinib Patent Granted in the U.S.
03/12/2025 -
Extendicare Completes Previously Announced $200 Million Private Placement of Common Shares
03/12/2025 -
Oncotelic and Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing
03/12/2025 -
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
03/12/2025 -
Aeroflow Urology Donates $30,000 to Support Family-Centered Care
03/12/2025
Pages